Molecular mechanisms of sequence-dependent antitumor effects of SN-38 and 5-fluorouracil combination therapy against colon cancer cells

Anticancer Res. 2009 Jun;29(6):2083-9.

Abstract

Background: The aim of this study was to clarify the molecular mechanisms of the sequence-dependent antitumor activity of SN-38 and 5-fluorouracil (5-FU) against colon cancer cells.

Materials and methods: KM12SM and HCT116 colon cancer cells were exposed to 5-FU and/or SN-38 in various conditions. The nature of interactions was determined by median-effect analysis. Cell cycle, apoptosis, and expression of thymidylate synthase (TS) were analyzed.

Results: A strong synergism was observed after initial sequential exposure of SN-38, and the activity was enhanced by a 24 h-interval to the drug-exposure. Antagonism was observed after low-dosage initial sequential exposure of 5-FU. Low-dosage 5-FU caused G(2) arrest and high-dosage 5-FU caused G(1) arrest. TS protein level significantly decreased after exposure to SN-38.

Conclusion: The sequence dependency between SN-38 and 5-FU against colon cancer cells may be related to the dual action on cell cycle regulation by 5-FU and to the down-regulation of TS level by SN-38.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / pharmacology*
  • Apoptosis / drug effects*
  • Blotting, Western
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives
  • Cell Proliferation / drug effects*
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / metabolism
  • Dose-Response Relationship, Drug
  • Flow Cytometry
  • Fluorouracil / administration & dosage
  • G1 Phase / drug effects*
  • G2 Phase / drug effects*
  • Humans
  • Irinotecan
  • Thymidylate Synthase / metabolism
  • Tumor Cells, Cultured

Substances

  • Irinotecan
  • Thymidylate Synthase
  • Fluorouracil
  • Camptothecin